← All companies ← CRNX Manual CROX → ← CRNX Pharmaceuticals CTMX →
CRON, Cronos Group Inc. Common Share
Revenue is Cannabis flower (74%) and Cannabis extracts (26%).
With a passion to responsibly elevate the consumer experience, Cronos is building an iconic brand portfolio.
Cronos' diverse international brand portfolio includes Spinach , PEACE NATURALS , LIT , and Lord Jones .
The business
What it sells, where the money comes from, the kind of company it is.
Next report By 11/8 · the 10-Q for the quarter ended late September · due within 40 days of period end · has filed ~38 days after · the wire records it on arrival
The business in brief
read the 10-K →What this business is and what moves its needle, from its own SEC filings.
- What it is
- A pharmaceutical business, where patents grant a temporary monopoly the pipeline must keep refilling.
- Situation
- Net current asset value. Current assets alone exceed every liability combined, and the surplus is most of the balance sheet: the shape Graham called a net-net.
- What moves the needle
- Operating margin has run around −169% through the cycle on a 18% gross margin, the operating line deeply negative — so the lever is the path to a margin at all: revenue growth against the cost curve and the cash runway, not the level of a margin that isn't there yet. Inventory runs near 43% of sales, so how fast it turns back into cash — and the risk of writing it down when demand softens — sits alongside the margin. Read this kind of business on the pipeline against the patent cliff, and pricing. On its own account, the filing leans hardest on pricing power & competition, set against the numbers in what the filing emphasizes, below.
- Is it a good business?
- Return on capital has rarely cleared the cost of capital (median −23%, above 15% in 0 of 9 years). Owner earnings, the cash-based check, have been thin too. This is price-taker territory, where the balance sheet and the cycle matter more than any multiple; the rest is in the 10-K.
Every line is arithmetic on the company's filings, shown in full in the sections below.
Where the money comes from
read the 10-K →Cannabis flower is 74% of revenue, with Cannabis extracts the other meaningful line at 26%.
- Cannabis flower74%$108M
- Cannabis extracts26%$38M
- Other0%$411K
From the segment footnote of the company's own 10-K. Shares are of total revenue; the profit bar shows each segment's share of segment operating profit, before unallocated corporate costs.
The record
Ten years of arithmetic, read across the cycle.
The record, 2017–2025
realized figures from each filing · older years to the left| 2017’17 | 2018’18 | 2019’19 | 2020’20 | 2021’21 | 2022’22 | 2023’23 | 2024’24 | 2025’25 | TTMTTMJun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| $3M | $12M | $24M | $47M | $65M | $87M | $87M | $118M | $147M | $179M | RevenueRevenue |
| $2M | $6M | ($18M) | ($26M) | ($18M) | $15M | $12M | $25M | $63M | — | Gross profitGross prof. |
| 50% | 51% | −74% | −55% | −27% | 18% | 14% | 21% | 43% | — | Gross marginGross mgn |
| 170% | 131% | 440% | 246% | 173% | 99% | 83% | 58% | 43% | 38% | SG&A / revenueSG&A/rev |
| 0% | 15% | 51% | 44% | 34% | 15% | 7% | 4% | 3% | 3% | R&D / revenueR&D/rev |
| ($6M) | ($20M) | ($153M) | ($219M) | ($292M) | ($111M) | ($85M) | ($77M) | ($17M) | ($2M) | Operating incomeOp. inc. |
| −194.5% | −168.7% | −645.5% | −469.6% | −452.2% | −128.4% | −97.2% | −65.1% | −11.9% | −1.4% | Operating marginOp. mgn |
| ($2M) | ($21M) | $1.2B | ($73M) | ($129M) | ($121M) | ($74M) | $37M | ($17M) | — | Pretax incomePretax |
| ($1M) | ($22M) | $1.2B | ($73M) | ($396M) | ($169M) | ($74M) | $41M | ($9M) | $70M | Net incomeNet inc. |
| Cash flow & returns | ||||||||||
| ($4M) | ($8M) | ($131M) | ($145M) | ($154M) | ($89M) | ($43M) | $19M | $26M | $60M | Operating cash flowOp. cash |
| $768K | $2M | $4M | $7M | $15M | $13M | $8M | $9M | $14M | $14M | Depreciation & amortizationD&A |
| ($5M) | $4M | ($1.3B) | ($94M) | $217M | $52M | $14M | ($40M) | $14M | ($31M) | Working capital & otherWC & other |
| $33M | $88M | $39M | $31M | $11M | $3M | $3M | $12M | $26M | $10M | CapexCapex |
| n/m | 728.6% | 162.8% | 67.2% | 17.3% | 4.0% | 2.9% | 10.6% | 17.5% | 5.7% | Capex / revenueCapex/rev |
| ($5M) | ($9M) | ($135M) | ($152M) | ($165M) | ($92M) | ($45M) | $10M | $12M | $50M | Owner earningsOwner earn. |
| −160.3% | −78.0% | −570.4% | −325.2% | −255.2% | −106.5% | −52.0% | 8.1% | 7.9% | 27.8% | Owner earnings marginOE mgn |
| ($37M) | ($96M) | ($170M) | ($176M) | ($165M) | ($92M) | ($45M) | $6M | $149K | $50M | Free cash flowFCF |
| n/m | −790.6% | −715.2% | −377.3% | −255.2% | −106.5% | −52.0% | 5.5% | 0.1% | 27.8% | Free cash flow marginFCF mgn |
| $0 | $0 | $224M | $0 | $0 | — | — | — | — | $0 | AcquisitionsAcquis. |
| — | — | — | — | — | — | $0 | $0 | $10M | — | BuybacksBuybacks |
| ($30M) | ($94M) | ($603M) | $20M | ($29M) | ($2M) | ($59M) | $175M | ($77M) | — | Investing cash flowInv. cash |
| $39M | $122M | $1.9B | ($3M) | ($13M) | ($3M) | ($1M) | ($1M) | ($20M) | — | Financing cash flowFin. cash |
| ($152K) | ($4M) | $52M | $6M | $5M | ($29M) | $8M | ($3M) | $4M | — | Exchange-rate effectFX |
| $5M | $17M | $1.2B | ($122M) | ($191M) | ($122M) | ($95M) | $190M | ($67M) | — | Change in cashΔ cash |
| -9% | -13% | -28% | -27% | -51% | -23% | -16% | -37% | -5% | -0% | ROICROIC |
| -2% | -15% | 67% | -4% | -30% | -15% | -7% | 4% | -1% | 7% | Return on equityROE |
| −2% | −15% | 67% | −4% | −30% | −15% | −7% | 4% | −1% | 7% | Retained to equityRetained/eq |
| Balance sheet | ||||||||||
| $7M | $24M | $1.5B | $1.3B | $1.0B | $878M | $862M | $859M | $832M | $797M | Cash & investmentsCash+inv |
| — | $3M | $5M | $9M | $22M | $23M | $14M | $15M | $34M | $37M | ReceivablesReceiv. |
| — | $7M | $38M | $44M | $33M | $38M | $30M | $33M | $47M | $53M | InventoryInvent. |
| — | $1M | $9M | $19M | $11M | $11M | $12M | $17M | $12M | $17M | Accounts payablePayables |
| — | $9M | $33M | $34M | $44M | $50M | $32M | $32M | $69M | $72M | Operating working capitalOper. WC |
| — | $40M | $1.6B | $1.4B | $1.1B | $960M | $933M | $936M | $944M | $912M | Current assetsCur. assets |
| — | $33M | $333M | $207M | $54M | $68M | $41M | $50M | $48M | $56M | Current liabilitiesCur. liab. |
| — | 1.2× | 4.7× | 6.6× | 19.9× | 14.1× | 22.5× | 18.8× | 19.6× | 16.2× | Current ratioCurr. ratio |
| — | $126M | $160M | $188M | $74M | $61M | $59M | $133M | $146M | — | Net PP&ENet PP&E |
| $1M | $1M | $214M | $180M | $1M | $1M | $1M | $63M | $66M | $64M | GoodwillGoodwill |
| — | $183M | $2.1B | $1.9B | $1.4B | $1.2B | $1.1B | $1.2B | $1.2B | $1.2B | Total assetsAssets |
| ($7M) | ($24M) | ($1.5B) | ($1.3B) | ($1.0B) | ($878M) | ($862M) | ($859M) | ($832M) | ($797M) | Net debt / (cash)Net debt |
| -60.6× | -147.1× | -123.2× | -1179.5× | -10813.7× | -8571.4× | — | — | — | -186.8× | Interest coverageInt. cov. |
| — | $35M | $341M | $218M | $63M | $72M | $44M | $55M | $54M | — | Total liabilitiesTotal liab. |
| — | $100K | ($853K) | ($3M) | ($3M) | ($3M) | ($3M) | $47M | $49M | — | Noncontrolling interestsNCI |
| $64M | $148M | $1.7B | $1.7B | $1.3B | $1.1B | $1.1B | $1.1B | $1.1B | $1.1B | Shareholders’ equityEquity |
| 61.4% | 67.2% | 48.9% | 32.9% | 15.7% | 17.4% | 10.1% | 7.4% | 4.8% | 3.6% | Stock comp / revenueSBC/rev |
| — | — | — | $35M | $37K | — | — | — | $700K | $700K | Goodwill written downGW imp. |
| Per share | ||||||||||
| 177M | 172M | 343M | 352M | 370M | 377M | 381M | 386M | 383M | 378M | Shares out (diluted)Shares |
| $0.02 | $0.07 | $0.07 | $0.13 | $0.17 | $0.23 | $0.23 | $0.31 | $0.38 | $0.47 | Revenue / shareRev/sh |
| $-0.01 | $-0.13 | $3.40 | $-0.21 | $-1.07 | $-0.45 | $-0.19 | $0.11 | $-0.02 | $0.18 | EPS (diluted)EPS |
| $-0.03 | $-0.05 | $-0.40 | $-0.43 | $-0.44 | $-0.25 | $-0.12 | $0.02 | $0.03 | $0.13 | Owner earnings / shareOE/sh |
| $-0.21 | $-0.56 | $-0.50 | $-0.50 | $-0.44 | $-0.25 | $-0.12 | $0.02 | $0.00 | $0.13 | Free cash flow / shareFCF/sh |
| $0.19 | $0.51 | $0.11 | $0.09 | $0.03 | $0.01 | $0.01 | $0.03 | $0.07 | $0.03 | Cap. spending / shareCapex/sh |
| $0.36 | $0.86 | $5.10 | $4.87 | $3.61 | $3.03 | $2.89 | $2.76 | $2.85 | $2.82 | Book value / shareBVPS |
The diluted share count moved ×1.99 into 2019 — shares issued, not a split the totals corroborate — and the per-share figures carry the counts as filed.
| 8-yr | 5-yr | |
|---|---|---|
| Revenue / share | +46.7%/yr | +23.5%/yr |
| Capital spending / share | −12.0%/yr | −5.6%/yr |
| Book value / share | +29.5%/yr | −10.1%/yr |
Net income is the accountant's number; owner earnings is the cash an owner could take out. The walk between them, off the cash-flow statement, and whether the gap is widening or holding.
In fiscal 2025 the business earned $12M of owner earnings, the operating cash left after the $14M it takes just to hold its position. It put $11M more into growth; free cash flow, after that spending, was $149K.
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|
| Reported net income | ($9M) | $41M | ($74M) | ($169M) | ($396M) |
| Depreciation & amortizationnon-cash charge added back | +$14M | +$9M | +$8M | +$13M | +$15M |
| Stock-based compensationreal costnon-cash, but a real cost | +$7M | +$9M | +$9M | +$15M | +$10M |
| Working capital & othertiming of cash in and out, other non-cash items | +$14M | −$40M | +$14M | +$52M | +$217M |
| Cash from operations | $26M | $19M | ($43M) | ($89M) | ($154M) |
| Maintenance capital expenditurethe spending needed just to hold position and volume | −$14M | −$9M | −$3M | −$3M | −$11M |
| Owner earnings | $12M | $10M | ($45M) | ($92M) | ($165M) |
| Growth capital expenditurediscretionary; spent to get bigger, not to stand still | −$11M | −$3M | — | — | — |
| Free cash flow | $149K | $6M | ($45M) | ($92M) | ($165M) |
| Owner-earnings marginowner earnings ÷ revenue | 8% | 8% | -52% | -107% | -255% |
Owner earnings is the cash an owner could pull out without starving the business: operating cash less the maintenance capital it must spend to hold its position (here about $14M, roughly its depreciation, the rate its assets wear out). The other $11M of its capital spending is growth it chose, not upkeep it owed; charged only with the maintenance it must do, the business earns well more than the year's free cash flow shows. The cash-flow statement also adds stock comp back as non-cash, but it is a real cost paid in shares; counted as the expense it is (less $7M), owner earnings is nearer $5M.
Maintenance capex is estimated as depreciation where a growing business invests above it; free cash flow is the figure the scorecard's free-cash margin reads.
Quality & stewardship
Returns, the balance sheet, capital allocation, and pay.
Owner’s Scorecard
Will it survive?
- No meaningful interest burdenLittle or no interest expense reported
What this means
Little or no interest expense reported, the business isn't leaning on lenders to operate.
- Net cash, debt-freeCash $792M + ST investments $40M − debt $0
What this means
Cash and short-term investments exceed every dollar of debt by $832M, on net the company owes nothing, and can act from strength when others can't. Net debt is the leverage figure that matters: the cash is already set against the debt. Strategic or illiquid investments aren't counted here.
- Not enough data
What this means
The filing data didn't include the inputs for this check.
Is it a good business?
- Not enough dataIndustry peers: median -12%
What this means
The filing data didn't include the inputs for this check.
- Positive this year, negative across the cyclelatest $12M = operating cash $26M − maintenance capex $14M (positive this year), after an earlier loss stretch (9-yr median -107%)Industry peers: median -34%
What this means
What an owner could take out without starving the business: operating cash less the maintenance capital it must spend to hold its position — Buffett's owner earnings. That's 8% of revenue this year, a -107% median across 9 years. It chose to put $11M more into growth, so free cash flow this year was $149K — the gap is investment, not weakness. Treating stock comp as the real expense it is (less $7M of SBC) leaves $5M.
- Loss, but cash-generativeNet income ($9M) · cash from operations $26M
In the filing’s words And the filing leans heavily on adjusted, non-GAAP earnings — steering you off the GAAP figure just where the cash is not backing it. Read the reconciliation in the notes before taking the adjusted number.
What this means
The company reported a net loss, so a conversion ratio isn't meaningful. What matters then is whether operations still threw off cash, here, they did.
How is the cash used?
- Returns about halfDividends + buybacks $10M ÷ Owner Earnings $12M — this fiscal year
What this means
Of $12M Owner Earnings, $10M (84%) went back to shareholders, $0 dividends, $10M buybacks. Net of $7M stock comp, the real buyback was about $3M. Returning most of it is the mark of a mature business with little left to reinvest at a high return; reinvesting most could mean a long runway, or empire-building. The split doesn't say which; the return earned on it (see ROIC) does.
- Investing or harvesting? 1.81×ExpandingCapex $26M ÷ depreciation & amortization as filed $14M
What this means
Descriptive, not a grade. Above ~1× means investing faster than assets wear out (growth, or, sustained for years, today's earnings carrying less depreciation than tomorrow's will). Below means spending less than it's wearing out (efficiency, or a melting asset base). The ratio won't tell you which; the filings will.
The promise and the pay packet
- Sells itselfSelling and marketing $22M ÷ revenue $147M
What this means
Sales and marketing as a share of revenue, kept apart from administrative overhead because it answers a different question: how much a business must spend to win the next customer. A company whose product pulls customers in spends little here and keeps the difference; one that must buy its growth is running to stand still, and the spending has to keep rising for revenue to keep rising. Read it beside the growth rate, not alone.
- Is the buyback buying ownership, or mopping up? 4.8%The buyback only stands stillStock compensation $7M (fiscal 2025), 4.8% of revenue · repurchases $10M · diluted shares +1.7% since 2022
What this means
Stock handed to employees is a real cost paid in the owner's own currency: it is charged against profit, but the shares it creates are permanent. Many companies repurchase stock at the same time, which looks like a return of capital and often is not — if the count barely moves, the cash merely cancelled the pay packet and bought the owner nothing. The three states worth telling apart are a count genuinely shrinking, a count standing still despite large repurchases, and a count rising because the issuance was never offset at all.
Graham’s defensive tests · 1 of 4 met
Graham’s numerical criteria for the defensive investor (The Intelligent Investor, ch. 14), run on the filings. A floor of safety, not a buy signal; many fine modern businesses fail his strictest liquidity rules by design.
- Adequate size MissRevenue ≥ $2B · $147M
What this means
Big enough to weather a storm. Graham's 1972 floor was ~$100M of sales (≈ $700M today); we use a $2B revenue line as a conservative modern stand-in.
- Strong liquidity PassCurrent ratio ≥ 2× · 19.59×
What this means
Current assets at least twice current liabilities, near-term bills covered without touching the business. Strict by design: many cash-rich modern firms run leaner and miss it, holding their cushion in longer-dated securities.
- Earnings stability MissA profit every year (9-yr record) · 7 loss years
What this means
Graham wanted earnings in each of the past ten years, the stability a defensive owner leans on.
- Dividend record —Uninterrupted dividends · no dividend line tagged in the data
What this means
An unbroken dividend was Graham's mark of durability. This record carries no dividends-paid line in any year — common for partnerships, whose distributions file under tags the chain doesn't read — so the criterion is withheld rather than judged on silence.
- Earnings growth MissEarnings +33% over the record · −104%
What this means
At least a third more earnings than a decade ago, averaging three years at each end. Net income (not per-share), so stock splits don't distort it, buybacks and dilution show up in the share-count line instead.
- Moderate price —P/E ≤ 15 and P/E × P/B ≤ 22.5 · decided by the price
What this means
Graham's valuation gate, the wall he kept between a sound business and a sound investment. Three-year average earnings are $-0.04/share (latest year $-0.03), the averaged base the calculator's gate runs on, and book value is $2.97/share. Enter a price in “What the price implies” just below for the P/E, P/B, and whether it clears. But this is the rule Buffett outgrew: there's no hard P/E law, and a wonderful business can deserve a far richer multiple if the thesis holds, treat it as the bargain-hunter's floor, not a verdict on the price.
Durability & moat, 2017–2025
Whether the record’s returns held, and what the capital reinvested earned.
- Profitable years 2 of 9
What this means
Lost money in 7 year(s), look at what happened there before trusting the average.
- Operating margin −336% → −58% (3-yr avg ends)
In the filing’s words The margin widened even though the filing names price competition — the gain came from volume or cost, not pricing power. Read where.
What this means
Through the cycle the operating margin widened — about −336% early to −58% lately, median −169% — pricing power intact or improving.
- Worst year 2019 · −645.5% op. margin
What this means
Operations went underwater in 2019, understand why before trusting the good years.
All figures as filed; the source filing is linked above.
Current Position
as of the latest quarter, Jun 30, 2026Can the business pay what it owes this year, off the freshest balance sheet: the quality of the assets, the debt actually coming due, and what a low ratio means here.
- Cash & short-term investments$797M
- Receivables$37M
- Inventory$53M
- Other current assets$26M
- Accounts payable$17M
- Other current liabilities$39M
From the company's latest filing.
Acquisitions & goodwill
from the balance sheet & the 9-year cash-flow recordGoodwill grows only when a company acquires and falls only when it concedes it overpaid. The size of that bet, the cash put into buying rather than building, and how much has already been written off.
$36M written down across 3 years (2020, 2021, 2025): goodwill the company has already conceded it overpaid for, charged against earnings. That is roughly 16% of the cash it put into acquisitions over the span. A write-down costs no cash (the cash went out when the deal was signed), but it is management marking its own past judgment to market.
Beside that spending sits $10M of cumulative amortization of acquired intangibles charged against earnings since fiscal 2017 — the purchase price of past deals, expensed over time.
Goodwill, acquired intangibles and equity from the latest balance sheet; acquisition spend and amortization summed across the company's full tagged history, write-downs across the 9-year record, from the company's own filings.
Management, ownership & pay
read the proxy →From the proxy: how much of the business the people running it own, and how they are paid, beside what the business earned for its owners in the same years.
| Fiscal year | Chief executive | Pay, as filed | “Actually paid” | Owner earnings |
|---|---|---|---|---|
| 2021 | Michael Gorenstein | $2.5M | −$4.4M | ($165M) |
| 2022 | Michael Gorenstein | $16.5M | $13.0M | ($92M) |
| 2022 | Michael Gorenstein | $728k | −$1.6M | ($92M) |
| 2023 | Michael Gorenstein | $3.7M | $2.0M | ($45M) |
| 2024 | Michael Gorenstein | $4.2M | $3.9M | $10M |
| 2025 | Michael Gorenstein | $4.1M | $4.9M | $12M |
Both pay figures are the company’s own, from the pay-versus-performance table its proxy statement files. “As filed” is the Summary Compensation Table total: salary, bonus, and equity awards at their value on the day of grant. “Actually paid” is the SEC’s prescribed recalculation, which re-marks those equity awards to what they became as they vested; it can swing far above or below the filed figure in either direction, and negative years occur. Owner earnings are the whole business's, from the record above, for the same fiscal years.
- Insider ownership7.8%
The stake all directors and executive officers hold together, per the 2026 proxy: skin in the game, the first thing Munger reads.
- Stock-based compensation$7M
The slice of the business handed to employees in shares in fiscal 2025, 4.8% of revenue. Buffett's oldest accounting fight: this is compensation, compensation is an expense, real whether or not the headline earnings admit it. One trap: the cash-flow statement adds SBC back, so the operating cash, and the owner earnings drawn from it, are flattered by exactly this amount; counted as the cost it is, what an owner keeps is lower.
What an owner would ask, FY2025
read the 10-K →- Which reported numbers are a judgment call?Management names Credit & receivables, Stock compensation as critical estimates
each rests partly on management's judgment; the filing's note sets out the assumptionsverify →
The questions the record and the charts do not answer on their own; each carries the figure and the place to look.
Peers, Pharmaceuticals
The same industry, side by side on owner economics. Each column names the period it is read over, and a median resting on fewer than three years carries that count beside it; the group median at the foot is the line to read each figure against.
| Company | Revenuelatest FY, USD | Gross marginmedian over the record | Op. marginmedian over the record | ROICmedian over the record | Owner earn. marginmedian over the record |
|---|---|---|---|---|---|
| ACBAurora Cannabis Inc. | $248M | — | -115.3% | -7% | -84% |
| GLASGlass House Brands Inc. | $182M | 41% | -21.6% | -12% | -11% |
| KMDAKamada Ltd. | $180M | 36% | 9.8% | 11% | 9% |
| CYRXCryoPort Inc. | $176M | 46% | -44.0% | -14% | -17% |
| LQDALiquidia Corporation | $158M | 76% | -341.3% | -163% | -255% |
| CRONCronos Group Inc. Common Share | $147M | -7% | -168.7% | -23% | -107% |
| AAPGASCENTAGE PHARMA GROUP INTERNATIONAL | $145M | 90% | -376.9% | -53%2y | -330% |
| XNCRXencor Inc. | $126M | — | -69.2% | -12% | -34% |
| Group median | — | 43% | -92.3% | -13% | -59% |
The price
What a price has to assume.
What the price implies
reverse-DCFType today's close and see the owner-earnings growth you'd have to believe to justify it, beside what Cronos Group Inc. Common Share has delivered.
—
9.0% = the 4.65% 10-year Treasury (Aug 19, 2026) + 4.35 points of equity premium. The rate you require is yours to set.
Enter a price above to run it.
A dated snapshot of the price you typed, the assumptions you set, and what the page showed for them. A snapshot is never edited after it is saved. Your notebook is yours alone — the commitment states what is stored and what we will never do.
Graham capped the multiple at 15×; Buffett and Munger let that rule go: a wonderful business can deserve 50× if the thesis holds. The gate marks the bargain-hunter's floor.
Prefilled with the 10-year Treasury (4.65%, as of Aug 19, 2026). Edit it for today’s exact figure, or a AAA corporate yield.
Graham measured a stock against the bond you could own instead, the heart of his margin of safety. Enter a price above to weigh the owner-earnings yield against this bond.
Owner earnings $50M on 368M shares outstanding, per the 10-Q cover, as of 2026-08-03; net cash $797M. The base is the latest year by default; Normalize values it on the through-cycle median owner-earnings margin (to avoid paying on a peak year). Net of stock comp treats option pay as the expense it is. The dials set the multiple a growth belief justifies; the price, and every dollar on this page, is yours.
Manual order: ← CRNX its page in the Manual CROX →
Industry order: ← CRNX the Pharmaceuticals chapter CTMX →